Diarrhea: all 865 studies

Page 2 of 9. Open to participants first (77), then studies with results posted, then the rest; newest registration first within each.

• The GRAFT Study: Gut RecolonizAtion by Fecal TransplantationCompletedNCT03621657Phase 2Results posted
• Study of BBIL's ROTAVAC® and ROTAVAC 5CM Vaccines in ZambiaCompletedNCT03602053Phase 2/3Results posted
• Study Confirming A Human Challenge Model and Investigating The Safety Of VLA1701CompletedNCT03576183Phase 2Results posted
• Combination Probiotic: BB-12 With LGG (Different Doses) in Treating Children With Autism Spectrum DisorderCompletedNCT03514784Phase 1/2Results posted
• S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary AmyloidosisCompletedNCT03499808Phase 2Results posted
• Study to Evaluate the Efficacy and Safety of Racecadotril in Children Aged 3 to 60 Months Suffering From Acute DiarrheaCompletedNCT03473561Phase 3Results posted
• Controlled Study to Evaluate the Efficacy and Safety of Racecadotril in Infants, Children and Adolescents With Acute DiarrheaCompletedNCT03463512Phase 3Results posted
• Efficacy of Oral Vancomycin Prophylaxis for Prevention of Recurrent Clostridium Difficile InfectionCompletedNCT03462459Phase 2Results posted
• Efficacy and Safety of CB-01-11 200mg Tablets in Infectious DiarrhoeaCompletedNCT03447821Phase 2Results posted
• Eluxadoline Bile Acid Malabsorption (BAM) StudyCompletedNCT03441581Phase 4Results posted
• Dose Escalating Study of a Prototype CS6 Subunit Vaccine With a Modified Heat-labile Enterotoxin From Enterotoxigenic Escherichia Coli (ETEC)CompletedNCT03404674Phase 1Results posted
• TOX NEG Trial: Clostridium Difficile Diagnosis and TreatmentCompletedNCT03388268Phase 4Results posted
• Improvements Through the Use of a Rapid Multiplex PCR Enteric Pathogen Detection Kit in Children With HematocheziaCompletedNCT03362970Not applicableResults posted
• Trial to Understand Efficacy of Colesevelam in Diarrhea Predominant IBS Patients With Bile Acid MalabsorptionCompletedNCT03270085Phase 2Results posted
• Efficacy and Safety of BB-12 Supplemented Strawberry Yogurt For Healthy Children on AntibioticsCompletedNCT03181516Phase 2Results posted
• Chronic Administration of Diosmectite (SMECTA®) in Subjects With Chronic DiarrhoeaCompletedNCT03045926Phase 1Results posted
• Budesonide for Mycophenolic Acid-induced Diarrhea in Renal Transplant RecipientsTerminatedNCT02991768Phase 2Results posted
• Efficacy of Eluxadoline in the Treatment of Irritable Bowel Syndrome With Diarrhea in Patients With Inadequate Control of Symptoms With Prior Loperamide UseCompletedNCT02959983Phase 4Results posted
• Probiotic Yogurt Supplement in Reducing Diarrhea in Patients With Metastatic Kidney Cancer Being Treated With Vascular Endothelial Growth Factor-Tyrosine Kinase InhibitorCompletedNCT02944617Not applicableResults posted
• Shigella WRSS1 Vaccine Trial in BangladeshCompletedNCT02934178Phase 1Results posted
• A Study Comparing Two Rifaximin Tablets in Patients With Travelers' Diarrhea.TerminatedNCT02920242Phase 3Results posted
• Diarrhea Prevention and Prophylaxis With Crofelemer in HER2 Positive Breast Cancer PatientsCompletedNCT02910219Phase 2Results posted
• Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of BEKINDA (Ondansetron 12 mg Bimodal Release Tablets) for Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)CompletedNCT02757105Phase 2Results posted
• C. Difficile and UrsodiolCompletedNCT02748616Phase 4Results posted
• To Assess Safety, Tolerability and Efficacy of LJN452 in Patients With Primary Bile Acid Diarrhea.CompletedNCT02713243Phase 2Results posted
• Prevention of Clostridium Difficile-associated Diarrhea by Daily Intake of KefirTerminatedNCT02707198Phase 2Results posted
• Efficacy of Diosmectite (Smecta®) in the Symptomatic Treatment of Acute Diarrhoea in AdultsCompletedNCT02704091Phase 4Results posted
• Manage Diarrhea in Patients With Multiple Myeloma While Receiving Conditioning Chemotherapy for Autologous SCTTerminatedNCT02619812Phase 2Results posted
• Enterotoxigenic Escherichia Coli (ETEC) ETVAX Vaccine Trial in BangladeshCompletedNCT02531802Phase 1/2Results posted
• Study Comparing Rifaximin With Xifaxan 200 mg in Traveler's DiarrheaCompletedNCT02498418Phase 3Results posted
• Fecal Microbiota Transplantation to Treat Recurrent C. Difficile Associated Diarrhea Via Retention Enema or Oral RouteCompletedNCT02449174Phase 1/2Results posted
• The Efficacy of PX0612 In The Treatment Of Irritable Bowel SyndromeCompletedNCT02431533Not applicableResults posted
• Azithromycin to Prevent Post-discharge Morbidity and Mortality in Kenyan ChildrenActive, not recruitingNCT02414399Phase 4Results posted
• An Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and LoperamideCompletedNCT02400476Phase 2Results posted
• Dose Finding Study in Colorectal Cancer Patients Receiving 5-FU-based Chemotherapy to Assess the Efficacy of Elsiglutide in the Prevention of Chemotherapy Induced Diarrhea (CID)CompletedNCT02383810Phase 2Results posted
• Fecal Microbiota Transplantation for the Treatment of Diarrhea-Predominant Irritable Bowel SyndromeCompletedNCT02328547Phase 2Results posted
• Using Behaviour Change Messaging to Improve Communal Toilets in Dhaka, BangladeshCompletedNCT02324075Not applicableResults posted
• Fresh, Frozen or Lyophilized Fecal Microbiota Transplantation for Multiple Recurrent C. Difficile Associated DiarrheaCompletedNCT02318992Phase 1/2Results posted
• Study of Prophylactic Octreotide to Prevent or Reduce the Frequency and Severity of Diarrhoea in Subjects Receiving Lapatinib With Capecitabine for the Treatment of Metastatic Breast CancerTerminatedNCT02294786Phase 2Results posted
• Immune Response to Rotavirus Vaccine After a Supplemental Dose Given at 9 Months of Age With Local EPI Vaccines in MaliCompletedNCT02286895Phase 4Results posted
• Efficacy of Rifaximin in Preventing CampylobacteriosisCompletedNCT02280044Phase 2/3Results posted
• Lactose-free Milk in Infants With Acute Diarrhea in a Developing CountryTerminatedNCT02246010Not applicableResults posted
• Effect of Ranolazine on Gastrointestinal Motor Function and Pain in Patients With IBS-DTerminatedNCT02239926Phase 2/3Results posted
• A Study to Investigate the Safety and Efficacy of Fidaxomicin (Oral Suspension or Tablets) and Vancomycin (Oral Liquid or Capsules) in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD)CompletedNCT02218372Phase 3Results posted
• Efficacy of Metronidazole Prophylaxis Against Clostridium Difficile-Associated Diarrhea in High Risk Adult PatientsTerminatedNCT02200328Phase 4Results posted
• 52-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)TerminatedNCT02120027Phase 3Results posted
• Ability of Mayo Clinic High-performance Liquid Chromatography (HPLC) Method to Measure Fecal Bile AcidsCompletedNCT02111603Phase 4Results posted
• 12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)CompletedNCT02107196Phase 3Results posted
• Impact of Oral Antibiotic Treatment on C. DifficileCompletedNCT02057198Phase 4Results posted
• CASAD for Severe Diarrhea in the Emergency DepartmentTerminatedNCT02018653Not applicableResults posted
• Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile - Associated DiarrheaCompletedNCT01987895Phase 3Results posted
• Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile-associated DiarrheaCompletedNCT01983683Phase 3Results posted
• Safety and Efficacy of IQP-MM-101 in Reducing Symptoms of DiarrhoeaCompletedNCT01969214Not applicableResults posted
• An Alternate Dosing Schedule for Pentavalent Rotavirus Vaccine (RotaTeq)CompletedNCT01960725Phase 4Results posted
• Microbiota Restoration Therapy for Recurrent Clostridium Difficile-associated DiarrheaCompletedNCT01925417Phase 2Results posted
• Causes of Rotavirus Vaccine Failure in Zambian ChildrenCompletedNCT01886833Results posted
• ADAM-Afatinib Diarrhea Assessment and ManagementCompletedNCT01814553Phase 3Results posted
• Safety Study of Live Attenuated Oral Shigella (WRSS1) Vaccine in Bangladeshi Adults and ChildrenCompletedNCT01813071Not applicableResults posted
• Live Attenuated ETEC Vaccine ACE527 With and Without dmLT Adjuvant in AdultsCompletedNCT01739231Phase 1/2Results posted
• Trial of Ceramic Water Filters to Reduce Cryptosporidium Infection in KenyaCompletedNCT01695304Not applicableResults posted
• Safety and Efficacy of Fidaxomicin Versus Placebo for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation (MK-5119-001)CompletedNCT01691248Phase 3Results posted
• Efficacy of Lactobacillus GG With Diosmectite in Treatment Children With Acute GastroenteritisCompletedNCT01657032Phase 4Results posted
• A Study of CB-183,315 in Participants With Clostridium Difficile Associated Diarrhea (MK-4261-006)CompletedNCT01598311Phase 3Results posted
• Study of CB-183,315 in Participants With Clostridium Difficile Associated Diarrhea (MK-4261-005)CompletedNCT01597505Phase 3Results posted
• Safety, Tolerability, and Pharmacokinetics of Fidaxomicin in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD)CompletedNCT01591863Phase 2Results posted
• Obeticholic Acid in Bile Acid DiarrhoeaCompletedNCT01585025Phase 2Results posted
• Proof-of-Concept, Calcium Aluminosilicate Anti-Diarrheal (CASAD) for Treatment of Clostridium Difficile InfectionTerminatedNCT01570634Phase 2Results posted
• Efficacy, Safety, and Tolerability of Eluxadoline in the Treatment of Participants With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d)CompletedNCT01553747Phase 3Results posted
• Efficacy, Safety, and Tolerability of Eluxadoline in the Treatment of Participants With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d)CompletedNCT01553591Phase 3Results posted
• Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment StudyCompletedNCT01543178Phase 3Results posted
• Efficacy and Safety of a New Oral Rehydration Solution (Hipp ORS 200 Apple) in Children With Acute GastroenteritisCompletedNCT01467570Phase 4Results posted
• Vaccine Effectiveness of RV1 in a Naïve PopulationCompletedNCT01467037Results posted
• Glutamine for the Treatment of Patients With Irritable Bowel SyndromeCompletedNCT01414244Phase 2Results posted
• Pharmacokinetics and Safety of Tigecycline in the Treatment of Clostridium Difficile Associated Diarrhea (CDAD)CompletedNCT01401023Not applicableResults posted
• Exploration of the Biologic Basis for Underperformance of Oral Polio and Rotavirus Vaccines in BangladeshCompletedNCT01375647Phase 3Results posted
• Safety and Tolerability of Crofelemer for HIV-Associated DiarrheaCompletedNCT01374490Phase 3Results posted
• Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell TransplantationCompletedNCT01371656Phase 3Results posted
• Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) With LACTEOL® 340 mgTerminatedNCT01358708Phase 3Results posted
• Efficacy of Mesalamine in Diarrhea-predominant Irritable Bowel Syndrome (dIBS)CompletedNCT01327300Phase 2Results posted
• Ibodutant for Relief of Irritable Bowel Syndrome With Diarrhoea (IBS-D)CompletedNCT01303224Phase 2Results posted
• Rifamycin SV-MMX® Tablets Versus Ciprofloxacin Capsules in Acute Traveller's DiarrhoeaCompletedNCT01208922Phase 3Results posted
• Oral Zinc for the Treatment of Acute Diarrhea in US ChildrenCompletedNCT01198587Not applicableResults posted
• Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation TherapyCompletedNCT01198145Phase 3Results posted
• Mesalamine Granules for Irritable Bowel Syndrome (IBS) With DiarrheaCompletedNCT01177410Phase 2Results posted
• Probiotic Saccharomyces Boulardii for the Prevention of Antibiotic-associated DiarrhoeaTerminatedNCT01143272Phase 3Results posted
• Study to Evaluate Safety and Efficacy of Rifamycin SV Multi-Matrix System (MMX) for the Treatment of Traveler's Diarrhea (TD)CompletedNCT01142089Phase 3Results posted
• Efficacy, Safety, and Tolerability of JNJ-27018966 (Eluxadoline) in the Treatment of Irritable Bowel Syndrome With DiarrheaCompletedNCT01130272Phase 2Results posted
• Study of CB-183,315 in Participants With Clostridium Difficile InfectionCompletedNCT01085591Phase 2Results posted
• Safety and Efficacy Study of WRSS1, a Shigella Sonnei Vaccine CandidateCompletedNCT01080716Phase 1/2Results posted
• Safety and Immunogenicity Study of Traveler's Diarrhea Vaccine PatchCompletedNCT01067781Phase 2Results posted
• Effect of Probiotic Lactobacilli (Lacidofil Cap®) for the Prevention of Antibiotic-Associated DiarrheaCompletedNCT01058356Results posted
• Micronutrient Sprinkles in a Daycare CenterCompletedNCT00967551Phase 3Results posted
• Efficacy and Safety Study in the Prevention of Antibiotic-Associated Diarrhea (AAD) and Clostridium Difficile-Associated Diarrhea (CDAD) in Hospitalized Adult Patients Exposed to Nosocomial InfectionCompletedNCT00958308Phase 3Results posted
• Does Welchol (Colesevelam Hydrochloride) Improve Colonic Transit in Diarrhea-predominant Irritable Bowel Syndrome (D-IBS)?CompletedNCT00911612Phase 2Results posted
• Lanreotide Autogel in the Symptomatic Treatment of Refractory DiarrheaCompletedNCT00891371Phase 2/3Results posted
• Probiotics and Hospital Outcome in the ElderlyCompletedNCT00794924Not applicableResults posted
• Phase I Randomized, Placebo-Controlled, Double-Blind, Dose Ranging Study, Safety, Tolerability and ImmunogenicityTerminatedNCT00772954Phase 1Results posted
• Traveler's Diarrhea (TD) Automated ProcessCompletedNCT00751777Phase 2Results posted
• Calcium Aluminosilicate Anti-Diarrheal in Treating and Preventing Diarrhea in Patients With Metastatic Colorectal Cancer Receiving IrinotecanCompletedNCT00748215Phase 2Results posted
• Rifaximin for Prevention of Travellers' DiarrheaCompletedNCT00742469Phase 3Results posted

← Diarrhea overview